Cargando…
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382664/ https://www.ncbi.nlm.nih.gov/pubmed/25794130 http://dx.doi.org/10.1038/bcj.2015.23 |
_version_ | 1782364617252536320 |
---|---|
author | Roy, V Stewart, A K Bergsagel, P L Dispenzieri, A Laumann, K Allred, J Lacy, M Q Fonseca, R Reeder, C B Kumar, S Rivera, C E Gertz, M A Buadi, F K Hayman, S R Rajkumar, S V |
author_facet | Roy, V Stewart, A K Bergsagel, P L Dispenzieri, A Laumann, K Allred, J Lacy, M Q Fonseca, R Reeder, C B Kumar, S Rivera, C E Gertz, M A Buadi, F K Hayman, S R Rajkumar, S V |
author_sort | Roy, V |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4382664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-43826642015-04-07 Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation Roy, V Stewart, A K Bergsagel, P L Dispenzieri, A Laumann, K Allred, J Lacy, M Q Fonseca, R Reeder, C B Kumar, S Rivera, C E Gertz, M A Buadi, F K Hayman, S R Rajkumar, S V Blood Cancer J Letter to the Editor Nature Publishing Group 2015-03 2015-03-20 /pmc/articles/PMC4382664/ /pubmed/25794130 http://dx.doi.org/10.1038/bcj.2015.23 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Letter to the Editor Roy, V Stewart, A K Bergsagel, P L Dispenzieri, A Laumann, K Allred, J Lacy, M Q Fonseca, R Reeder, C B Kumar, S Rivera, C E Gertz, M A Buadi, F K Hayman, S R Rajkumar, S V Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation |
title | Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation |
title_full | Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation |
title_fullStr | Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation |
title_full_unstemmed | Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation |
title_short | Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation |
title_sort | phase i/ii study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382664/ https://www.ncbi.nlm.nih.gov/pubmed/25794130 http://dx.doi.org/10.1038/bcj.2015.23 |
work_keys_str_mv | AT royv phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT stewartak phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT bergsagelpl phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT dispenzieria phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT laumannk phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT allredj phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT lacymq phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT fonsecar phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT reedercb phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT kumars phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT riverace phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT gertzma phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT buadifk phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT haymansr phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation AT rajkumarsv phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation |